93.7%
Gustave RoussyREISAMICsolid or hematologic malignanciesadvanced or metastatic canceradvanced/metastatic canceranti-PD-(L)1anti-programmed death-ligand 1 (PD-(L)1)
…ethods We conducted a single-center prospective cohort study at Gustave Roussy (Villejuif, France), based on a population of patients with adv…